WPG Advisers
MRNA icon

WPG Advisers’s Moderna MRNA Stock Holding History

WPG Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.27K Buy
17
+2
+13% +$216 ﹤0.01% 1054
2026
Q2 		$1.05K Hold
15
– – ﹤0.01% 1319
2026
Q1 		$762 Hold
15
– – ﹤0.01% 1305
2025
Q4 		$442 Hold
15
– – ﹤0.01% 1395
2025
Q3 		$387 Hold
15
– – ﹤0.01% 1391
2025
Q2 		$414 Hold
15
– – ﹤0.01% 1365
2025
Q1 		$425 Hold
15
– – ﹤0.01% 1364
2024
Q4 		$624 Buy
+15
New +$717 ﹤0.01% 1303

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

WPG Advisers's MRNA Position: Q3 2026 in Review

WPG Advisers increased its Moderna (MRNA) stake by 13% in Q3 2026, buying an estimated $216 and bringing the position to 17 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

WPG Advisers first reported a position in MRNA in Q4 2024 and has held it in 8 quarters since. 582 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • WPG Advisers held 17 shares of Moderna worth $3.27K as of Q3 2026.
  • WPG Advisers bought 2 Moderna shares in Q3 2026, an estimated $216.
  • Moderna made up ﹤0.01% of WPG Advisers's portfolio in Q3 2026, its #1054 holding.
  • WPG Advisers first reported a position in Moderna in Q4 2024 and has held it in 8 quarters since.
  • 582 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.